tiprankstipranks
Holding PBE?
Track your performance easily

PBE Price & Analysis

PBE ETF Chart & Stats

Day’s Range― - ―
52-Week Range$52.45 - $67.73
Previous Close$64.51
VolumeN/A
Average Volume (3M)14.15K
AUM245.61M
NAV64.65
Expense Ratio0.58%
Holdings Count32
Beta0.85
Inception DateJun 23, 2005
0.04 (―)
Shares Outstanding4,020,000
Standard Deviation0.06
10 Day Avg. Volume6,621
30 Day Avg. Volume14,149
Alpha-0.00459

PBE ETF FAQ

What was PBE’s price range in the past 12 months?
PBE lowest ETF price was $52.45 and its highest was $67.73 in the past 12 months.
    What is the AUM of PBE?
    As of Mar 25, 2024 The AUM of PBE is 245.61M.
      Is PBE overvalued?
      According to Wall Street analysts PBE’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
        Does PBE pay dividends?
        PBE pays a Annually dividend of $0.02 which represents an annual dividend yield of N/A. See more information on PBE dividends here
          How many shares outstanding does PBE have?
          PBE has 4,020,000 shares outstanding.
            Which hedge fund is a major shareholder of PBE?
            Currently, no hedge funds are holding shares in PBE

            PBE ETF Smart Score

            For ETFs, the calculations for the Smart Score, Analyst Consensus, Price Target, Blogger Sentiment, News Sentiment and Insider Transactions are based on the weighted average of the ETF's holdings and some additional factors. Hedge Fund Trend, Crowd Wisdom and Technicals are based on the actual ETF ticker.​

            Top 10 Holdings

            Name
            Weight %
            Neurocrine Biosciences
            5.29%
            Regeneron Pharmaceuticals
            5.05%
            Gilead Sciences
            4.99%
            Vertex Pharmaceuticals Inc.
            4.94%
            Amgen Inc
            4.94%
            Biomarin Pharmaceutical Inc.
            4.91%
            Bio-Techne
            4.83%
            Biogen Inc.
            4.80%
            MannKind Corporation
            3.69%
            Collegium Pharmaceutical Inc.
            3.37%
            Total46.82%

            ETF Description

            Invesco Dynamic Biotechnology & Genome ETF

            PBE tracks a tiered equal-weighted index of companies principally engaged in biotechnology and genetic engineering.
            Sector
            Sector
            Asset Class
            Equity
            Region
            North America
            Issuer
            Invesco
            Index Tracked
            Dynamic Biotech & Genome Intellidex Index (AMEX)
            Ticker Symbol
            PBE
            Popular ETFs
            What's Included in PREMIUM?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis